Neuroprotection in the treatment of glaucoma – A focus on connexin43 gap junction channel blockers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neuroprotection in the treatment of glaucoma – A focus on connexin43 gap junction channel blockers

Published:2015-09 Issue: Volume:95 Page:182-193
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Chen Ying-Shan,Green Colin R.,Danesh-Meyer Helen V.,Rupenthal Ilva D.

Funder

Auckland Medical Research Foundation

Buchanan Charitable Foundation

Health Research Council of New Zealand

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference191 articles.

1. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;Br. J. Ophthalmol.,2006

2. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage;Quigley;Ophthalmology,1992

3. Glaucomas. Diagnosis and management;Paton;Clin. Symp.,1976

4. Primary open-angle glaucoma;Weinreb;The Lancet,2004

5. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma;Gordon;Arch. Ophthalmol.,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases;Journal of Nanobiotechnology;2024-06-20

2. Role of N6-methyladenosine-related lncRnas in pseudoexfoliation glaucoma;Epigenetics;2024-05-08

3. Modulation of Rac1/PAK1/connexin43‐mediated ATP release from astrocytes contributes to retinal ganglion cell survival in experimental glaucoma;Glia;2023-02-16

4. The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics;Experimental Eye Research;2022-02

5. In Situ Gelling Electrospun Ocular Films Sustain the Intraocular Pressure-Lowering Effect of Timolol Maleate: In Vitro, Ex Vivo, and Pharmacodynamic Assessment;Molecular Pharmaceutics;2021-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3